Identification and in vitro Characterization of Novel Antidiabetic Peptides Released Enzymatically from Peanut Protein

Improvement of egg yolk powder properties through ultrasound coupled sodium sulfite pretreatment assisted enzymatic hydrolysis and underlying mechanism

Egg yolk is an excellent protein source for the production of bioactive peptides. However, the recent method need to remove lipid first which involves wastage and pollution of organic reagents. Therefore, the process of directly using oily yolk powder to prepare egg yolk peptides has attracted much attention. This study developed a one-step process to simultaneously extract oil and hydrolyze proteins based on an ultrasound coupled sodium sulfite pretreatment (UCSSP) assisted enzymatic hydrolysis for egg yolk powder. Results showed that UCSSP increased the oil extraction rate from zero to 75 % with 59.35 g/L of soluble protein and 33.99 g/L of peptide. Further analysis of the underlying mechanism demonstrated that ultrasound pre-treatment could change the secondary structure of EYP while sodium sulfite pre-treatment softened the protein and induced more hydrophobic groups exposed, thus inducing more lipoprotein released for hydrolysis. In addition, the proportion of peptides ranging from 180 Da to 3000 Da in the UCSSP group increased from 31.19 % before to 79.74 %, which was 31.27 % and 6.16 % higher than that of UP and SP. Furthermore, the obtained peptides showed obvious activities in uric acid-lowering, anti-obesity and antioxidant with 56.24 % inhibition in XOD activity and close antioxidant activity to vitamin C, implying it a potential health product.

In vitro and In vivo Determination of Biological Activities of Bitter Gourd (Momordica charantia L.) Peel, Flesh and Seeds

Momordica charantia L. has been remained a well-known medicinal vegetable used traditionally. However, which part is most effective against which disorder, has been remained undiscovered yet. The objective of this study was to examine the antimicrobial, antihyperlipidemic and antihyperglycemic activities of peel, flesh, and seeds of bitter gourd, through in vitro and in vivo assays. Ethanolic extracts from powders of three fractions of bitter gourd were assessed for antimicrobial potential against bacterial and fungal strains, whereas, powders of these fractions were used to determine antihyperlipidemic and antihyperglycemic activity, in alloxan induced diabetic rats. Our results showed that BSE exhibited better antimicrobial activity against Bacillus cereus, whereas BFE exhibited better against Escherichia coli. Blood glucose was significantly lowered by all three powders in a dose dependent manner, when fed to diabetic rats, with the highest decrease by BSP, which reduced the glucose level from 296.20 ± 2.00 mg/dl to 123.10 ± 0.80 mg/dl, at 15 mg dose, after 28 days trial. Elevated levels of TC (101.18 ± 0.65 mg/dl), TG (83.69 ± 0.61 mg/dl) and LDL-C (25.90 ± 0.09 mg/dl) in positive control rats were lowered down in well manners by BSP at 15 mg dose, to 86.30 ± 0.53, 67.70 ± 0.53 and 19.32 ± 0.06 mg/dl, respectively. As compared to BFP and BPP, BSP showed significant involvement in antibacterial, antihyperglycemic, and antihyperlipidemic actions. Along with the edible flesh, peels and seeds, which are usually discarded as waste, could also be utilized for development of pharma foods capable of promoting health.